Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Phenylephrine/ketorolac
Подписчиков: 0, рейтинг: 0
Combination of | |
---|---|
Phenylephrine | Alpha-1 adrenergic receptor agonist |
Ketorolac | Nonsteroidal anti-inflammatory |
Clinical data | |
Trade names | Omidria |
AHFS/Drugs.com | Monograph |
License data | |
Routes of administration |
Intraocular |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
KEGG |
Phenylephrine/ketorolac, sold under the brand name Omidria, is a combination drug used during cataract surgery or intraocular lens replacement to prevent intraoperative miosis and to reduce postoperative pain. It contains phenylephrine and ketorolac.
Phenylephrine/ketorolac was approved for medical use in the United States in May 2014, and in the European Union in July 2015.
External links
- "Ketorolac mixture with phenylephrine". Drug Information Portal. U.S. National Library of Medicine.
Receptor (ligands) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enzyme (inhibitors) |
|
||||||||||||||||||||||||||
Others | |||||||||||||||||||||||||||